Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study; Grant "Optimizing Tolerance Induction in Peanut Allergy: The DEVIL Study"
Phase of Trial: Phase I/II
Latest Information Update: 20 Apr 2017
At a glance
- Drugs AR 101 (Primary)
- Indications Peanut hypersensitivity
- Focus Therapeutic Use
- Acronyms DEVIL
- 17 Apr 2017 Status changed from active, no longer recruiting to completed.
- 08 Sep 2016 New trial record
- 05 Sep 2016 Results of a retrospective pooled analysis from three trials (n=104) published in the Journal of Allergy and Clinical Immunology